Akt2 deficiency impairs Th17 differentiation, augments Th2 differentiation, and alters the peripheral response to immunization
Akt1 and Akt2, isoforms of the serine threonine kinase Akt, are essential for T cell development. However, their role in peripheral T cell differentiation remains undefined. Using mice with germline deletions of either Akt1 or Akt2, we found that both isoforms are important for Th17 differentiation,...
Saved in:
| Published in | bioRxiv |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article Paper |
| Language | English |
| Published |
United States
Cold Spring Harbor Laboratory
10.06.2024
|
| Edition | 1.1 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2692-8205 2692-8205 |
| DOI | 10.1101/2024.06.07.598023 |
Cover
| Summary: | Akt1 and Akt2, isoforms of the serine threonine kinase Akt, are essential for T cell development. However, their role in peripheral T cell differentiation remains undefined. Using mice with germline deletions of either Akt1 or Akt2, we found that both isoforms are important for Th17 differentiation, although Akt2 loss had a greater impact than loss of Akt1. In contrast to defective IL-17 production, Akt2
T cells exhibited enhanced IL-4 production
under Th2 polarizing conditions.
, Akt2
mice displayed significantly diminished IL-17A and GM-CSF production following immunization with myelin oligodendrocyte glycoprotein (MOG). This dampened response was associated with further alterations in Th cell differentiation including decreased IFNγ production but preserved IL-4 production, and preferential expansion of regulatory T cells compared to non-regulatory CD4 T cells. Taken together, we identify Akt2 as an important signaling molecule in regulating peripheral CD4 T cell responses. |
|---|---|
| Bibliography: | ObjectType-Working Paper/Pre-Print-3 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interest Statement: The authors have declared no competing interest. |
| ISSN: | 2692-8205 2692-8205 |
| DOI: | 10.1101/2024.06.07.598023 |